Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modified lipoproteins in diabetes

J P Deslypere1

  • 1Department of Endocrinology and Metabolism, University Hospital, Gent, Belgium.

Journal of Internal Medicine. Supplement
|January 1, 1994
PubMed
Summary

Diabetes can cause tissue damage through oxidized lipoproteins, particularly low-density lipoprotein (LDL). Antioxidants and certain inhibitors show promise in reducing harmful lipid peroxides in diabetic patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

News and views in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): The role of co-morbidity and novel treatments.

Medical hypotheses·2019
Same author

Post-SARS psychological morbidity and stigma among general practitioners and traditional Chinese medicine practitioners in Singapore.

Annals of the Academy of Medicine, Singapore·2004
Same author

Lipids and coronary heart disease in Asia.

Atherosclerosis·2003
Same author

Genetic causes of familial hypercholesterolaemia in a Malaysian population.

The Medical journal of Malaysia·2001
Same author

Low-density lipoprotein receptor gene mutations in a Southeast Asian population with familial hypercholesterolemia.

Clinical genetics·2000
Same author

Low density lipoprotein cholesterol lowering: are the treatment guidelines still appropriate?

International journal of clinical practice·2000

Area of Science:

  • Biochemistry
  • Pathophysiology
  • Endocrinology

Background:

  • Diabetes mellitus is associated with various tissue damage mechanisms.
  • Modified lipoproteins, especially oxidized low-density lipoprotein (LDL), are implicated in diabetic complications.
  • Other lipid abnormalities are also prevalent in diabetic patients.

Purpose of the Study:

  • To elucidate the role of modified lipoproteins in diabetes-induced tissue damage.
  • To investigate the pathways of lipoprotein oxidation in diabetic patients.
  • To explore potential therapeutic interventions targeting lipid abnormalities.

Main Methods:

  • Analysis of lipoprotein modification, focusing on oxidation processes.
  • Investigation of enzymatic and nonenzymatic oxidation pathways.
  • Measurement of lipid peroxide concentrations in diabetic and non-diabetic subjects.

Main Results:

  • Oxidized LDL is rapidly internalized by macrophages, forming foam cells.
  • Two oxidation pathways (enzymatic and nonenzymatic) identified in diabetics, targetable by acetyl salicylic acid or antioxidants.
  • Higher glucose levels contribute to free radical generation, damaging proteins and collagen.
  • Diabetic patients exhibit elevated lipid peroxide levels, correlating with vascular complications and high triglycerides.
  • Antioxidant concentrations are lower in diabetics, and their levels can decrease lipid peroxides.
  • Preliminary data suggest HMG CoA reductase inhibitors may also reduce lipid peroxides.

Conclusions:

  • Oxidized lipoproteins and free radical generation are key contributors to diabetes-associated tissue damage.
  • Targeting lipoprotein oxidation and free radical pathways with antioxidants or specific inhibitors may mitigate diabetic complications.
  • Further research into lipid-modifying therapies like HMG CoA reductase inhibitors is warranted.

Related Experiment Videos